+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Oral Vaccine Market Research Report by Type, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 226 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 4995182
UP TO OFF until Dec 31st 2022
The Global Oral Vaccine Market size was estimated at USD 14.91 billion in 2021, USD 15.83 billion in 2022, and is projected to grow at a CAGR of 6.38% to reach USD 21.61 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Oral Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Attenuated and Inactive.
  • Based on Application, the market was studied across Cholera, HIV, Polio, Rabies, Respiratory Infection, and Tuberculosis.
  • Based on End User, the market was studied across Clinics and Hospitals.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Oral Vaccine market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Oral Vaccine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Oral Vaccine Market, including Bull Bio - NCIPD Ltd., Crucell (Johnson & Johnson), GlaxoSmithKline plc, Immunitor, Inc, Merck & Co., Inc., PaxVax Corporation, QUÍMICA SUIZA S.A., Serum Institute of India Pvt. Ltd., Shanghai BravoBio Co., Ltd., Shantha Biotechnics, Swiss Serum and Vaccine Institute Berne, VALNEVA Canada Inc., and Vaxart, Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Oral Vaccine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Oral Vaccine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Oral Vaccine Market?
4. What is the competitive strategic window for opportunities in the Global Oral Vaccine Market?
5. What are the technology trends and regulatory frameworks in the Global Oral Vaccine Market?
6. What is the market share of the leading vendors in the Global Oral Vaccine Market?
7. What modes and strategic moves are considered suitable for entering the Global Oral Vaccine Market?
Frequently Asked Questions about the Global Oral Vaccine Market

What is the estimated value of the Global Oral Vaccine Market?

The Global Oral Vaccine Market was estimated to be valued at $14.91 Billion in 2021.

What is the growth rate of the Global Oral Vaccine Market?

The growth rate of the Global Oral Vaccine Market is 6.3%, with an estimated value of $21.61 Billion by 2027.

What is the forecasted size of the Global Oral Vaccine Market?

The Global Oral Vaccine Market is estimated to be worth $21.61 Billion by 2027.

Who are the key companies in the Global Oral Vaccine Market?

Key companies in the Global Oral Vaccine Market include Bull Bio, NCIPD Ltd., Crucell (Johnson & Johnson), GlaxoSmithKline plc, Immunitor, Inc, Merck & Co., Inc., PaxVax Corporation, QUÍMICA SUIZA S.A. and Shanghai BravoBio Co., Ltd..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Surge in the demand for needle-free vaccines by the pharmaceutical industry
5.1.1.2. Growing incidences of infectious diseases in the emerging countries
5.1.1.3. Increasing demand for cost-effective oral vaccines by consumers
5.1.2. Restraints
5.1.2.1. Side effects associated with the use of oral vaccines
5.1.3. Opportunities
5.1.3.1. Rising development in the oral vaccines products
5.1.3.2. Increasing government fundings for the research activities
5.1.4. Challenges
5.1.4.1. High cost of development and storage of the oral vaccine
5.2. Cumulative Impact of COVID-19
6. Oral Vaccine Market, by Type
6.1. Introduction
6.2. Attenuated
6.3. Inactive
7. Oral Vaccine Market, by Application
7.1. Introduction
7.2. Cholera
7.3. HIV
7.4. Polio
7.5. Rabies
7.6. Respiratory Infection
7.7. Tuberculosis
8. Oral Vaccine Market, by End User
8.1. Introduction
8.2. Clinics
8.3. Hospitals
9. Americas Oral Vaccine Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Oral Vaccine Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Oral Vaccine Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Bull Bio - NCIPD Ltd.
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Crucell (Johnson & Johnson)
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. GlaxoSmithKline plc
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Immunitor, Inc
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Merck & Co., Inc.
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. PaxVax Corporation
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. QUÍMICA SUIZA S.A.
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Serum Institute of India Pvt. Ltd.
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Shanghai BravoBio Co., Ltd.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Shantha Biotechnics
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Swiss Serum and Vaccine Institute Berne
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. VALNEVA Canada Inc.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Vaxart, Inc.
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ORAL VACCINE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ORAL VACCINE MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 4. GLOBAL ORAL VACCINE MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL ORAL VACCINE MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. GLOBAL ORAL VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL ORAL VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL ORAL VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL ORAL VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL ORAL VACCINE MARKET DYNAMICS
FIGURE 11. GLOBAL ORAL VACCINE MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL ORAL VACCINE MARKET SIZE, BY TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL ORAL VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2027
FIGURE 14. GLOBAL ORAL VACCINE MARKET SIZE, BY ATTENUATED, 2018-2027 (USD BILLION)
FIGURE 15. GLOBAL ORAL VACCINE MARKET SIZE, BY INACTIVE, 2018-2027 (USD BILLION)
FIGURE 16. GLOBAL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 17. GLOBAL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD BILLION)
FIGURE 18. GLOBAL ORAL VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2027
FIGURE 19. GLOBAL ORAL VACCINE MARKET SIZE, BY CHOLERA, 2018-2027 (USD BILLION)
FIGURE 20. GLOBAL ORAL VACCINE MARKET SIZE, BY HIV, 2018-2027 (USD BILLION)
FIGURE 21. GLOBAL ORAL VACCINE MARKET SIZE, BY POLIO, 2018-2027 (USD BILLION)
FIGURE 22. GLOBAL ORAL VACCINE MARKET SIZE, BY RABIES, 2018-2027 (USD BILLION)
FIGURE 23. GLOBAL ORAL VACCINE MARKET SIZE, BY RESPIRATORY INFECTION, 2018-2027 (USD BILLION)
FIGURE 24. GLOBAL ORAL VACCINE MARKET SIZE, BY TUBERCULOSIS, 2018-2027 (USD BILLION)
FIGURE 25. GLOBAL ORAL VACCINE MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 26. GLOBAL ORAL VACCINE MARKET SIZE, BY END USER, 2021 VS 2027 (USD BILLION)
FIGURE 27. GLOBAL ORAL VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2027
FIGURE 28. GLOBAL ORAL VACCINE MARKET SIZE, BY CLINICS, 2018-2027 (USD BILLION)
FIGURE 29. GLOBAL ORAL VACCINE MARKET SIZE, BY HOSPITALS, 2018-2027 (USD BILLION)
FIGURE 30. AMERICAS ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 31. AMERICAS ORAL VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 32. AMERICAS ORAL VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 33. AMERICAS ORAL VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 34. ARGENTINA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 35. BRAZIL ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 36. CANADA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 37. MEXICO ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 38. UNITED STATES ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 39. UNITED STATES ORAL VACCINE MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 40. UNITED STATES ORAL VACCINE MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 41. UNITED STATES ORAL VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 42. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 43. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 44. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 45. ASIA-PACIFIC ORAL VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 46. AUSTRALIA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 47. CHINA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 48. INDIA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 49. INDONESIA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 50. JAPAN ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 51. MALAYSIA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 52. PHILIPPINES ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 53. SINGAPORE ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 54. SOUTH KOREA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 55. TAIWAN ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 56. THAILAND ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 57. VIETNAM ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 62. DENMARK ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 63. EGYPT ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 64. FINLAND ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 65. FRANCE ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 66. GERMANY ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 67. ISRAEL ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 68. ITALY ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 69. NETHERLANDS ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 70. NIGERIA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 71. NORWAY ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 72. POLAND ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 73. QATAR ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 74. RUSSIA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 75. SAUDI ARABIA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 76. SOUTH AFRICA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 77. SPAIN ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 78. SWEDEN ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 79. SWITZERLAND ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 80. TURKEY ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 81. UNITED ARAB EMIRATES ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 82. UNITED KINGDOM ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 83. GLOBAL ORAL VACCINE MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 84. GLOBAL ORAL VACCINE MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 85. GLOBAL ORAL VACCINE MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL ORAL VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 4. GLOBAL ORAL VACCINE MARKET SIZE, BY REGION, 2018-2027 (USD BILLION)
TABLE 5. GLOBAL ORAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 6. GLOBAL ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 7. GLOBAL ORAL VACCINE MARKET SIZE, BY ATTENUATED, 2018-2027 (USD BILLION)
TABLE 8. GLOBAL ORAL VACCINE MARKET SIZE, BY ATTENUATED, BY REGION, 2018-2027 (USD BILLION)
TABLE 9. GLOBAL ORAL VACCINE MARKET SIZE, BY ATTENUATED, BY REGION, 2018-2027 (USD BILLION)
TABLE 10. GLOBAL ORAL VACCINE MARKET SIZE, BY INACTIVE, 2018-2027 (USD BILLION)
TABLE 11. GLOBAL ORAL VACCINE MARKET SIZE, BY INACTIVE, BY REGION, 2018-2027 (USD BILLION)
TABLE 12. GLOBAL ORAL VACCINE MARKET SIZE, BY INACTIVE, BY REGION, 2018-2027 (USD BILLION)
TABLE 13. GLOBAL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 14. GLOBAL ORAL VACCINE MARKET SIZE, BY CHOLERA, 2018-2027 (USD BILLION)
TABLE 15. GLOBAL ORAL VACCINE MARKET SIZE, BY CHOLERA, BY REGION, 2018-2027 (USD BILLION)
TABLE 16. GLOBAL ORAL VACCINE MARKET SIZE, BY CHOLERA, BY REGION, 2018-2027 (USD BILLION)
TABLE 17. GLOBAL ORAL VACCINE MARKET SIZE, BY HIV, 2018-2027 (USD BILLION)
TABLE 18. GLOBAL ORAL VACCINE MARKET SIZE, BY HIV, BY REGION, 2018-2027 (USD BILLION)
TABLE 19. GLOBAL ORAL VACCINE MARKET SIZE, BY HIV, BY REGION, 2018-2027 (USD BILLION)
TABLE 20. GLOBAL ORAL VACCINE MARKET SIZE, BY POLIO, 2018-2027 (USD BILLION)
TABLE 21. GLOBAL ORAL VACCINE MARKET SIZE, BY POLIO, BY REGION, 2018-2027 (USD BILLION)
TABLE 22. GLOBAL ORAL VACCINE MARKET SIZE, BY POLIO, BY REGION, 2018-2027 (USD BILLION)
TABLE 23. GLOBAL ORAL VACCINE MARKET SIZE, BY RABIES, 2018-2027 (USD BILLION)
TABLE 24. GLOBAL ORAL VACCINE MARKET SIZE, BY RABIES, BY REGION, 2018-2027 (USD BILLION)
TABLE 25. GLOBAL ORAL VACCINE MARKET SIZE, BY RABIES, BY REGION, 2018-2027 (USD BILLION)
TABLE 26. GLOBAL ORAL VACCINE MARKET SIZE, BY RESPIRATORY INFECTION, 2018-2027 (USD BILLION)
TABLE 27. GLOBAL ORAL VACCINE MARKET SIZE, BY RESPIRATORY INFECTION, BY REGION, 2018-2027 (USD BILLION)
TABLE 28. GLOBAL ORAL VACCINE MARKET SIZE, BY RESPIRATORY INFECTION, BY REGION, 2018-2027 (USD BILLION)
TABLE 29. GLOBAL ORAL VACCINE MARKET SIZE, BY TUBERCULOSIS, 2018-2027 (USD BILLION)
TABLE 30. GLOBAL ORAL VACCINE MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2027 (USD BILLION)
TABLE 31. GLOBAL ORAL VACCINE MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2027 (USD BILLION)
TABLE 32. GLOBAL ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 33. GLOBAL ORAL VACCINE MARKET SIZE, BY CLINICS, 2018-2027 (USD BILLION)
TABLE 34. GLOBAL ORAL VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2027 (USD BILLION)
TABLE 35. GLOBAL ORAL VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2027 (USD BILLION)
TABLE 36. GLOBAL ORAL VACCINE MARKET SIZE, BY HOSPITALS, 2018-2027 (USD BILLION)
TABLE 37. GLOBAL ORAL VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD BILLION)
TABLE 38. GLOBAL ORAL VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD BILLION)
TABLE 39. AMERICAS ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 40. AMERICAS ORAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 41. AMERICAS ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 42. AMERICAS ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 43. AMERICAS ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 44. ARGENTINA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 45. ARGENTINA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 46. ARGENTINA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 47. ARGENTINA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 48. BRAZIL ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 49. BRAZIL ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 50. BRAZIL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 51. BRAZIL ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 52. CANADA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 53. CANADA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 54. CANADA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 55. CANADA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 56. MEXICO ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 57. MEXICO ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 58. MEXICO ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 59. MEXICO ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 60. UNITED STATES ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 61. UNITED STATES ORAL VACCINE MARKET SIZE, BY STATE, 2018-2027 (USD BILLION)
TABLE 62. UNITED STATES ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 63. UNITED STATES ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 64. UNITED STATES ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 65. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 66. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 67. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 68. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 69. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 70. AUSTRALIA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 71. AUSTRALIA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 72. AUSTRALIA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 73. AUSTRALIA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 74. CHINA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 75. CHINA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 76. CHINA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 77. CHINA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 78. INDIA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 79. INDIA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 80. INDIA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 81. INDIA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 82. INDONESIA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 83. INDONESIA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 84. INDONESIA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 85. INDONESIA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 86. JAPAN ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 87. JAPAN ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 88. JAPAN ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 89. JAPAN ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 90. MALAYSIA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 91. MALAYSIA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 92. MALAYSIA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 93. MALAYSIA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 94. PHILIPPINES ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 95. PHILIPPINES ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 96. PHILIPPINES ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 97. PHILIPPINES ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 98. SINGAPORE ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 99. SINGAPORE ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 100. SINGAPORE ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 101. SINGAPORE ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 102. SOUTH KOREA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 103. SOUTH KOREA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 104. SOUTH KOREA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 105. SOUTH KOREA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 106. TAIWAN ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 107. TAIWAN ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 108. TAIWAN ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 109. TAIWAN ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 110. THAILAND ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 111. THAILAND ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 112. THAILAND ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 113. THAILAND ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 114. VIETNAM ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 115. VIETNAM ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 116. VIETNAM ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 117. VIETNAM ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 123. DENMARK ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 124. DENMARK ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 125. DENMARK ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 126. DENMARK ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 127. EGYPT ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 128. EGYPT ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 129. EGYPT ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 130. EGYPT ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 131. FINLAND ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 132. FINLAND ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 133. FINLAND ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 134. FINLAND ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 135. FRANCE ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 136. FRANCE ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 137. FRANCE ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 138. FRANCE ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 139. GERMANY ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 140. GERMANY ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 141. GERMANY ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 142. GERMANY ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 143. ISRAEL ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 144. ISRAEL ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 145. ISRAEL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 146. ISRAEL ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 147. ITALY ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 148. ITALY ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 149. ITALY ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 150. ITALY ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 151. NETHERLANDS ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 152. NETHERLANDS ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 153. NETHERLANDS ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 154. NETHERLANDS ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 155. NIGERIA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 156. NIGERIA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 157. NIGERIA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 158. NIGERIA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 159. NORWAY ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 160. NORWAY ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 161. NORWAY ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 162. NORWAY ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 163. POLAND ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 164. POLAND ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 165. POLAND ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 166. POLAND ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 167. QATAR ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 168. QATAR ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 169. QATAR ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 170. QATAR ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 171. RUSSIA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 172. RUSSIA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 173. RUSSIA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 174. RUSSIA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 175. SAUDI ARABIA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 176. SAUDI ARABIA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 177. SAUDI ARABIA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 178. SAUDI ARABIA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 179. SOUTH AFRICA ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 180. SOUTH AFRICA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 181. SOUTH AFRICA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 182. SOUTH AFRICA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 183. SPAIN ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 184. SPAIN ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 185. SPAIN ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 186. SPAIN ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 187. SWEDEN ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 188. SWEDEN ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 189. SWEDEN ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 190. SWEDEN ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 191. SWITZERLAND ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 192. SWITZERLAND ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 193. SWITZERLAND ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 194. SWITZERLAND ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 195. TURKEY ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 196. TURKEY ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 197. TURKEY ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 198. TURKEY ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 199. UNITED ARAB EMIRATES ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 200. UNITED ARAB EMIRATES ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 201. UNITED ARAB EMIRATES ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 202. UNITED ARAB EMIRATES ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 203. UNITED KINGDOM ORAL VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 204. UNITED KINGDOM ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 205. UNITED KINGDOM ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 206. UNITED KINGDOM ORAL VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 207. GLOBAL ORAL VACCINE MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 208. GLOBAL ORAL VACCINE MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 209. GLOBAL ORAL VACCINE MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 210. GLOBAL ORAL VACCINE MARKET RANKING, BY KEY PLAYER, 2021
TABLE 211. GLOBAL ORAL VACCINE MARKET SHARE, BY KEY PLAYER, 2021
TABLE 212. GLOBAL ORAL VACCINE MARKET MERGER & ACQUISITION
TABLE 213. GLOBAL ORAL VACCINE MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 214. GLOBAL ORAL VACCINE MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 215. GLOBAL ORAL VACCINE MARKET INVESTMENT & FUNDING
TABLE 216. GLOBAL ORAL VACCINE MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 217. GLOBAL ORAL VACCINE MARKET: LICENSE & PRICING

Companies Mentioned

  • Bull Bio - NCIPD Ltd.
  • Crucell (Johnson & Johnson)
  • GlaxoSmithKline plc
  • Immunitor, Inc
  • Merck & Co., Inc.
  • PaxVax Corporation
  • QUÍMICA SUIZA S.A.
  • Serum Institute of India Pvt. Ltd.
  • Shanghai BravoBio Co., Ltd.
  • Shantha Biotechnics
  • Swiss Serum and Vaccine Institute Berne
  • VALNEVA Canada Inc.
  • Vaxart, Inc.

Methodology

Loading
LOADING...